High Vista Strategies LLC Galectin Therapeutics Inc Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.66 - $3.15 $41,998 - $79,695	-25,300 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.51 - $3.0 $7,399 - $14,700	-4,900 Reduced 16.23%	25,300 $50,000
Q4 2019 Feb 14, 2020	BUY	$2.79 - $4.32 $33,480 - $51,840	12,000 Added 65.93%	30,200 $86,000
Q3 2019 Nov 14, 2019	BUY	$3.0 - $4.05 $54,600 - $73,710	18,200 New	18,200 $67,000

9.65M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $137M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.